Novo Integrated Sciences Total Liabilities 2012-2024 | NVOS

Novo Integrated Sciences total liabilities from 2012 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Novo Integrated Sciences Annual Total Liabilities
(Millions of US $)
2024 $18
2023 $11
2022 $19
2021 $18
2020 $6
2019 $7
2018 $5
2017 $10
2016 $0
2016 $10
2015 $0
2014 $1
2013 $1
2012 $1
2012 $
2011 $2
2011 $
Novo Integrated Sciences Quarterly Total Liabilities
(Millions of US $)
2024-08-31 $18
2024-05-31 $26
2024-02-29 $13
2023-11-30 $14
2023-08-31 $11
2023-05-31 $9
2023-02-28 $10
2022-11-30 $17
2022-08-31 $19
2022-05-31 $27
2022-02-28 $26
2021-11-30 $20
2021-08-31 $18
2021-05-31 $6
2021-02-28 $6
2020-11-30 $6
2020-08-31 $6
2020-05-31 $6
2020-02-29 $6
2019-11-30 $7
2019-08-31 $7
2019-05-31 $6
2019-02-28 $4
2018-11-30 $5
2018-08-31 $5
2018-05-31 $5
2018-02-28 $5
2017-11-30 $9
2017-08-31 $10
2017-05-31 $10
2017-03-31 $0
2017-02-28
2016-12-31
2016-11-30
2016-09-30 $0
2016-06-30 $0
2016-05-31
2016-03-31 $0
2015-12-31
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31
2014-09-30 $1
2014-06-30 $1
2014-03-31 $1
2013-12-31
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $1
2012-09-30 $1
2012-08-31
2012-06-30 $1
2012-03-31 $2
2012-02-29
2011-12-31 $2
2011-11-30
2011-09-30
2011-08-31 $0
2011-06-30
2011-05-31 $0
2011-03-31
2011-02-28 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.002B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.312B 0.00
Quest Diagnostics (DGX) United States $18.153B 18.23
DaVita (DVA) United States $14.110B 18.25
Encompass Health (EHC) United States $9.934B 22.26
Chemed (CHE) United States $8.335B 25.62
Elanco Animal Health (ELAN) United States $5.917B 14.08
Option Care Health (OPCH) United States $5.245B 24.85
RadNet (RDNT) United States $4.764B 105.51
LifeStance Health (LFST) United States $3.053B 0.00
Amedisys (AMED) United States $3.017B 21.47
Addus HomeCare (ADUS) United States $2.171B 25.48
Astrana Health (ASTH) United States $2.001B 27.37
U.S Physical Therapy (USPH) United States $1.324B 34.81
Aveanna Healthcare Holdings (AVAH) United States $0.935B 0.00
Pennant (PNTG) United States $0.935B 37.81
Atai Life Sciences (ATAI) Germany $0.356B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00